Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma (original) (raw)
Lewis BP, Burge CB, Bartel DP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15–20. ArticleCASPubMed Google Scholar
Kent OA, Mendell JT . A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25:6188–6196. ArticleCASPubMed Google Scholar
Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S . The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007; 67:11001–11011. ArticleCASPubMed Google Scholar
le Sage C, Nagel R, Egan DA, et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007; 26:3699–3708. ArticleCASPubMedPubMed Central Google Scholar
Gillies JK, Lorimer IA . Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 2007; 6:2005–2009. ArticleCASPubMed Google Scholar
Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY . MiR-21-mediated tumor growth. Oncogene 2006; 26:2799–2803. ArticlePubMed Google Scholar
Chan JA, Krichevsky AM, Kosik KS . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029–6033. ArticleCASPubMed Google Scholar
Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065–7070. ArticleCASPubMed Google Scholar
Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY . MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18:350–359. ArticleCASPubMed Google Scholar
Krek A, Grun D, Poy M, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37:495–500. ArticleCASPubMed Google Scholar
Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB . Prediction of mammalian microRNA targets. Cell 2003; 115:787–798. ArticleCASPubMed Google Scholar
Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281–297. ArticleCASPubMed Google Scholar
Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647–658. ArticleCASPubMed Google Scholar
Zhu S, Si ML, Wu H, Mo YY . MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282:14328–14336. ArticleCASPubMed Google Scholar
Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283:1026–1033. ArticleCASPubMed Google Scholar
Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27:2128–2136. ArticleCASPubMed Google Scholar
Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769–773. ArticleCASPubMed Google Scholar
Wang X, Wang X . Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res 2006; 34:1646–1652. ArticleCASPubMedPubMed Central Google Scholar
Lim IK . TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol 2006; 132:417–426. ArticleCASPubMed Google Scholar
Melamed J, Kernizan S, Walden PD . Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 2002; 34:28–32. ArticleCASPubMed Google Scholar
Ficazzola MA, Fraiman M, Gitlin J, et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 2001; 22:1271–1279. ArticleCASPubMed Google Scholar
Struckmann K, Schraml P, Simon R, et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 2004; 64:1632–1638. ArticleCASPubMed Google Scholar
Kawakubo H, Carey JL, Brachtel E, et al. Expression of the NF-kappaB responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 2004; 23:8310–8319. ArticleCASPubMed Google Scholar
Guardavaccaro D, Corrente G, Covone F, et al. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 2000; 20:1797–1815. ArticleCASPubMedPubMed Central Google Scholar
Lim IK, Lee MS, Ryu MS, et al. Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol Carcinog 1998; 23:25–35. ArticleCASPubMed Google Scholar
Manjarrez ME, Ocadiz R, Valle L, et al. Gariglio P . Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res 2006; 12:6946–6951. ArticleCASPubMed Google Scholar
Carleton M, Cleary MA, Linsley PS . MicroRNAs and cell cycle regulation. Cell Cycle 2007; 6:2127–2132. ArticleCASPubMed Google Scholar
Seifer DB, MacLaughlin DT, Penzias AS, et al. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content. J Clin Endocrinol Metab 1993; 76:711–714. CASPubMed Google Scholar
Qian SB, Chen SS . Transduction of human hepatocellular carcinoma cells with human alpha-interferon gene via retroviral vector. World J Gastroenterol 1998; 4:210–213. ArticleCASPubMedPubMed Central Google Scholar